期刊文献+

微球制剂条件下胸腺肽α_1的稳定性评价 被引量:1

Stability evaluation of thymosin α_1 under microsphere preparation condition
在线阅读 下载PDF
导出
摘要 目的研究微球制剂工艺条件下胸腺肽α1的稳定性。方法采用高效液相色谱法(HPLC),研究胸腺肽α1在不同温度(-20℃、6~8℃、60℃)、不同超声时间(10~60s)及不同pH值(4.0、7.0、10.0)条件下的稳定性。结果胸腺肽α1在-20℃冷冻保存7d时仍很稳定,冷藏(6~8℃)时30d内可保持稳定,60℃水浴中12h内不降解;400W超声60s内不受影响;37℃时置于pH4.0的磷酸盐中12h内比较稳定。结论胸腺肽α1在本制备工艺条件下具有良好的稳定性。 Objective:To observe the stability of thymosin α_1 microspheres under preparation conditions.Methods: Using HPLC method,we investigated the influence of different temperatures(-20 ℃, 6-8℃,60℃),sonification time(10-60 s) and pH values (pH 4.0,7.0 and 10.0) on thymosin α_1 stability.Results: Under the conditions of frozen environment(-20℃) and refrigeration(6-8℃), thymosin α_1 remained stable for 30 d.Thymosin α_1 did not degrade in 60℃ water bath for 12 h or in phosphate buffer solution(PBS,pH 4.0) under 37℃ for 14 h.The sonification time within 60 s was found to be safe for the preparation.Conclusion: Thymosin α_1 is stable under these preparation conditions.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2005年第5期555-557,共3页 Academic Journal of Second Military Medical University
关键词 胸腺肽Α1 色谱法 高压液相 稳定性 微球 Thymosin α_1 chromatography,high pressure liquid stability microspheres
  • 相关文献

参考文献7

  • 1Cleland JL, Jones AJS. Stable formulations of recombinant human growth hormone and interferon-γ for microencapsulation in biodegradable microspheres[J]. Pharmaceut Res, 1996, 13(10):1464-1475.
  • 2Cleland JL. Solvent evaporation processes for the production of controlled release biodegradable microsphere formulations for therapeutics and vaccines[J]. Biotechnol Prog, 1998, 14(1):102-107.
  • 3Singh M, Shirley B, Bajwa K, et al. Controlled release of recombinant insulin-like growth factor from a novel formulation of polylactide-co-glycolide microparticles[J]. J Control Res, 2001,70(1-2):21-28.
  • 4刘莉,刘艳娟,周云久.反相高效液相色谱法测定胸腺肽中胸腺素α_1[J].黑龙江医药科学,1999,22(3):48-49. 被引量:2
  • 5Morlock M, Koll H, Winter G, et al. Microencapsulation of rh-erythropoietin, using biodegradable poly(D,L-lactide-co-glycolide): protein stability and the effects of stabilizing excipients[J]. Eur J Pharm Biopharm,1997,43(1):29-36.
  • 6Meinel L, Illi O E, Zapf J, et al. Stabilizing insulin-like growth factor-Ⅰ in poly(D,L-lactide-co-glycolide) microspheres[J]. J Control Rel, 2001, 70(1-2): 193-202.
  • 7Bodmer D, Kissel T,Traechslin E. Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems[J]. J Control Res,1992,21(1-3):129-138.

共引文献1

同被引文献16

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部